SIGA Technologies is a publicly traded company that was founded in 1995. SIGA is committed to the discovery, development and commercialization of novel products for the prevention and treatment of serious infectious diseases, including products for use in defense against biological warfare agents.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Head office
SIGA Technologies
420 Lexington Avenue
Suite 601
New York
New York
10170 New York
All rights reserved. Terms and Conditions | Contact us
